InMode Ltd. (INMD) stock declined over -0.98%, trading at $13.14 on NASDAQ, down from the previous close of $13.27. The stock opened at $13.29, fluctuating between $13.02 and $13.33 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Mar 11, 2026 | 13.29 | 13.33 | 13.02 | 13.14 | 448.21K |
| Mar 10, 2026 | 13.19 | 13.40 | 13.05 | 13.27 | 726.9K |
| Mar 09, 2026 | 13.10 | 13.30 | 12.95 | 13.29 | 1.46M |
| Mar 06, 2026 | 13.42 | 13.42 | 13.20 | 13.23 | 651.29K |
| Mar 03, 2026 | 13.51 | 13.65 | 13.37 | 13.60 | 568.26K |
| Mar 02, 2026 | 13.41 | 13.69 | 13.30 | 13.64 | 1.1M |
| Feb 27, 2026 | 13.96 | 13.98 | 13.71 | 13.75 | 812.99K |
| Feb 26, 2026 | 13.98 | 14.09 | 13.85 | 14.05 | 761.05K |
| Feb 25, 2026 | 13.97 | 14.15 | 13.91 | 13.96 | 759.13K |
| Feb 24, 2026 | 14.14 | 14.19 | 13.95 | 13.98 | 1.09M |
| Feb 23, 2026 | 14.11 | 14.37 | 13.91 | 14.20 | 2.33M |
| Feb 20, 2026 | 14.91 | 15.27 | 14.87 | 15.22 | 620.22K |
| Feb 19, 2026 | 14.43 | 15.11 | 14.37 | 15.10 | 1.38M |
| Feb 18, 2026 | 14.48 | 14.54 | 14.29 | 14.46 | 579.25K |
| Feb 17, 2026 | 14.30 | 14.54 | 14.23 | 14.48 | 750.5K |
| Feb 13, 2026 | 14.47 | 14.55 | 14.23 | 14.30 | 690.1K |
| Feb 12, 2026 | 14.25 | 14.48 | 14.25 | 14.30 | 1.2M |
| Feb 11, 2026 | 14.75 | 14.75 | 14.19 | 14.24 | 1.65M |
| Feb 10, 2026 | 14.46 | 15.39 | 14.46 | 14.62 | 1.29M |
| Feb 09, 2026 | 15.08 | 15.19 | 14.72 | 15.12 | 673.12K |
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
| Employees | 599 |
| Beta | 2.19 |
| Sales or Revenue | $492.05M |
| 5Y Sales Change% | 2.761% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep